The Future Of GLP-1 Policy After Drug Shortage Ends
By Avia Dunn, Maya Florence and Rachel Turow · December 18, 2024, 6:46 PM EST
Since 2022, four glucagon-like peptide-1 receptor agonists, also known as GLP-1 RA drugs — including those indicated for weight loss — have been on the U.S. Food and Drug Administration's drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login